ET's fourth-quarter earnings and revenues decline year over year. Total costs and expenses also decrease during the period.
CRSP reports encouraging fourth-quarter results. The commercial launch of the first CRISPR-based gene therapy, Casgevy, is ...
Equities researchers at Zacks Research lowered their Q2 2025 earnings per share estimates for PACCAR in a research report issued on Monday, February 10th. Zacks Research analyst R. Singhi now ...
7h
Zacks Investment Research on MSNNorthWestern (NWE) Q4 Earnings Match EstimatesNorthWestern (NWE) came out with quarterly earnings of $1.13 per share, in line with the Zacks Consensus Estimate. This compares to earnings of $1.38 per share a year ago. These figures are adjusted ...
7h
Zacks Investment Research on MSNKadant (KAI) Q4 Earnings Beat EstimatesKadant (KAI) came out with quarterly earnings of $2.25 per share, beating the Zacks Consensus Estimate of $2.08 per share. This compares to earnings of $2.41 per share a year ago. These figures are ...
Investment analysts at Zacks Research lifted their Q4 2024 earnings per share estimates for Motorola Solutions in a report released on Monday, February 10th. Zacks Research analyst R. Department now ...
The arguably more important measure of core inflation, which excludes price changes in the often volatile food and energy ...
BofA raised the firm’s price target on Zillow Group to $84 from $81 and keeps a Neutral rating on the shares. Q4 revenue and EBITDA beat expectations, but the Q1 outlook was bel ...
Barclays analyst Andrew Mok raised the firm’s price target on Humana (HUM) to $270 from $255 and keeps an Equal Weight rating on the shares.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results